About Bio Access Platforms
Bio Access Platforms is a company based in Palo Alto (United States) founded in 2023 by Armen Solakhyan. It operates as a SaaS and B2B. Bio Access Platforms offers products and services including Drug Revenue Forecaster and Drug Contract Pulse. Bio Access Platforms operates in a competitive market with competitors including Claritas Rx, BK Sciences, CuriousLabs, Summit ERP and Linkenpharma, among others.
- Headquarter Palo Alto, United States
- Founders Armen Solakhyan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bio Access Platforms
Bio Access Platforms offers a comprehensive portfolio of products and services, including Drug Revenue Forecaster and Drug Contract Pulse.
AI software for scalable drug revenue predictions and patient flow modeling.
Platform for automating drug contract tasks and scenario analysis.
Funding Insights of Bio Access Platforms
Detailed funding history for Bio Access Platforms
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bio Access Platforms
Investment portfolio details for Bio Access Platforms
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bio Access Platforms
Detailed financials for Bio Access Platforms
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bio Access Platforms Comparisons
Peer comparison for Bio Access Platforms
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bio Access Platforms
Bio Access Platforms operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claritas Rx, BK Sciences, CuriousLabs, Summit ERP and Linkenpharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Data integration and analytics services are offered to pharmaceutical manufacturers.
|
|
| Locked | Locked | Locked |
Software solutions are provided for analytical laboratories to streamline operations.
|
|
| Locked | Locked | Locked |
CuriousLabs is a business intelligence platform designed for pharmaceutical laboratories.
|
|
| Locked | Locked | Locked |
Provides comprehensive ERP software solutions for radiopharmaceutical manufacturers.
|
|
| Locked | Locked | Locked |
Offers business data analysis software specialized for pharmaceutical and nutraceutical sectors.
|
Detailed competitors of Bio Access Platforms
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bio Access Platforms
Complete news archive for Bio Access Platforms
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio Access Platforms
Bio Access Platforms was founded in 2023.
Bio Access Platforms is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Armen Solakhyan is the current CEO of Bio Access Platforms. They have also founded this company.
Bio Access Platforms provides AI-powered software to enhance access to medicines worldwide. It includes Drug Revenue Forecaster for precise, scalable revenue predictions and patient flow modeling, and Drug Contract Pulse for automating contract tasks and scenario analysis. These tools help pharmaceutical companies streamline operations, reduce costs, and make data-driven decisions efficiently, though specific locations are not detailed.
Bio Access Platforms's top competitors include Claritas Rx, BK Sciences and Moisaka.
Bio Access Platforms offers Drug Revenue Forecaster and Drug Contract Pulse.